OHBs, Capital

OHB's Capital Infusion: Institutions Buy In, Retail Opts Out as Stock Trades at a Discount to €300 Issue Price

Published on 07/21/2026 at 08:14 | Redaktion boerse-global.de

OHB SE's shares fall below €300 placement price after capital increase diluted core holders; record €3.35B order book and defense partnerships offer strategic support.

OHB SE Stock Struggles After €482M Capital Raise, Order Book Hits €3.35B Record
OHB's Capital Infusion: Institutions Buy In, Retail Opts Out as Stock Trades at a Discount to €300 Issue Price Illustration mit AI erstellt übermittelt durch boerse-global.de

The Frankfurt-listed shares of OHB SE have been caught in a tug-of-war between a freshly completed €482 million capital increase and a swelling order book that hit a record €3.35 billion. While institutional investors absorbed the bulk of the new stock, minority shareholders largely sat out the rights offer, and the stock has since drifted below the €300 placement price.

OHB's management executed the capital raising in two tranches, drawing on authorized capital from a June 22 board decision. The first tranche of 1,605,388 new shares was placed privately with international investors. A second tranche, registered with the commercial register on July 10, brought the total issuance to 1,702,480 new shares at €300 apiece, generating gross proceeds of approximately €482 million. The company's basic capital now stands at roughly €20.83 million.

Key to the deal's structure was the decision by core shareholders—the Fuchs family and Orchid Lux HoldCo S.à r.l., an entity linked to KKR—to forgo their subscription rights. This move deliberately widened the free float above the 20% threshold, diluting their combined holdings. In the subsequent rights offer, minority investors exercised claims for only 7,635 new shares, underscoring their limited appetite for the deal.

The stock's reaction has been telling. By the week ending July 19, shares closed at €243.00, an 8.82% weekly decline that left them 19% below the €300 subscription price. In a later session, the shares recovered to €246.00, gaining 2.07% on the day, but still stuck in a band well below the offer price. The 14-day relative strength index of 34.0 points to an oversold condition, while the 200-day moving average remains just 2.03% above the current price—a sign the long-term trend has not fully broken.

Should investors sell immediately? Or is it worth buying OHB SE?

To cushion the post-placement volatility, J.P. Morgan SE began stabilization trades on Xetra within a price corridor of €261.50 to €300.00. That support is scheduled to end on July 24, leaving the stock to find its own level.

Political and Strategic Reinforcements

Against this market backdrop, OHB has been fortifying its political and technological moorings. Defense Minister Boris Pistorius visited the Bremen headquarters on July 14, where CEO Marco Fuchs pressed the case for €35 billion in military space spending. Just days later, ESA director Laurent Jaffart toured the same facility, reaffirming cooperation on the Galileo and IRIS² programs as well as quantum communication.

The company is also deepening ties with Rheinmetall. In late June, the two firms hosted an "SME and Start-up Day" aimed at networking the German space ecosystem for the Bundeswehr's planned SATCOMBw 4 satellite communications system. Meanwhile, OHB is exploring mobile launch platforms beyond the North Sea—options in the Atlantic and near the equator for heavy payloads are being evaluated.

A new strategic partnership with Schwarz Digits, the IT arm of the Schwarz Group, intends to bring artificial intelligence into satellite manufacturing, targeting shorter development cycles and higher production efficiency in the New Space market.

Operational Strength Below the Price Action

Despite the share price weakness, the underlying business is firing on all cylinders. In the first quarter of 2026, total output rose 15% year-on-year to €279.3 million, while adjusted EBIT surged 63% to €16.8 million. The order backlog reached a record €3.35 billion, providing strong visibility.

Management has already raised its medium-term guidance. At the Capital Market Day in January, OHB forecast revenues above €2.0 billion by 2028 with an EBITDA margin exceeding 12%. The fresh capital from the increase is intended to accelerate investments in the space business, particularly in defense and satellite infrastructure.

Boardroom Changes and Dividend

The annual general meeting in early June approved a dividend of €0.60 per share for fiscal 2025. Shareholders also elected Dr. Theodor Weimer, former CEO of Deutsche Börse, to the supervisory board. On the operational side, Dr. Luis Alejandro Orellano assumed the role of Chief Operating Officer on July 1.

OHB SE at a turning point? This analysis reveals what investors need to know now.

These personnel shifts coincide with the changing ownership structure. With the free float now above 20% and the Fuchs family and KKR holding reduced positions, the investor base is more diverse than before. Market participants will watch closely how this broader ownership influences governance and strategic direction.

The Next Milestones

Investors are now looking to August 6, when OHB publishes its second-quarter 2026 report along with an earnings presentation. The results will offer the first glimpse of how the €482 million capital injection is feeding into operations. A month later, on September 21, management will present at the Berenberg & Goldman Sachs German Corporate Conference, another opportunity to court institutional investors.

For now, OHB's stock remains hostage to the arithmetic of dilution, even as the company's strategic narrative—space, defense, and AI—grows ever more compelling. The end of J.P. Morgan's stabilization support on July 24 will be the next test of whether the shares can find a floor on their own.

Ad

OHB SE Stock: New Analysis - 21 July

Fresh OHB SE information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated OHB SE analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | DE0005936124 | OHBS | boerse | 69819012 |